Correction of Bifidobacterium spp. and Lactobacillus spp. Populations in Mice with Experimental Intestinal Dysbiosis after Therapy with Enterosorbent-Immobilized Probiotics Stored at –80 and –196°C
DOI:
https://doi.org/10.15407/cryo25.03.267Keywords:
low-temperature storage, immobilized probiotics, intestinal dysbiosis, cenobionts, sorbents, miceAbstract
The research revealed the recovery of the Bifidobacterium spp. and Lactobacillus spp. cenobiont populations in mucin of mice with experimental intestinal dysbiosis after treatment with free and immobilized on enterosorbents probiotics, stored for a year at a temperature of –80, –196°C. Experimental intestinal dysbiosis was simulated by Ampicillin and Metronidazole oral administration. Mice with induced dysbiosis were treated with free cells of S. boulardii, B. bifidum, L. bulgaricus probiotics, the mixtures of free cells with enterosorbents as well as the complexes of probiotic cells immobilized on enterosorbents. The enterosorbents based on activated carbon Sorbex and SCMS-1 were used. Immobilized probiotics have been found to provide a more rapid and complete recovery of cenobiont populations. Low-temperature storage for a year (observation period) and temperature storage regimen did not affect the therapeutic properties of free and immobilized cells of probiotics. The mechanisms of action of immobilized probiotics are under discussion.
Probl Cryobiol Cryomed 2015; 25(3):267-286
References
Ardatskaya M.D. Prebiotics and probiotics in correction of microecological violations of intestinal tract. Pharmateca 2011; 225(12): 62–68.
Babinets O.M. Correction of dysbiosis by preparations of probiotics immobilized on enterosorbents after their low-temperature storage. Visnyk Problem Biologii i Meditsyny 2012; Issue 4, 1 (96): 72–78.
Babinets O.M. Estimation of properties of probiotics immobilized on enterosorbents after low-temperature storage. Visnyk Problem Biologii i Meditsyny 2012; (3, Part 2): 48–53.
Bondarenko A.V. Correction of dysbiotic states and stabilizing of microbiota. Problemy Bezperervnoyi Med Osvity ta Nauky 2014; (2): 77–80.
Bondarenko V.M. Substantiation and tactics of administration of different forms of probiotic preparations in medical practice. Pharmateca. 2012; 246 (13): 77–87.
Collins M.D., Gibson G.R. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 1999; 69 (5): 1052S–1057S. PubMed
Ding W.K., Shah N.P. Effect of various encapsulating materials on the stability of probiotic bacteria. J Food Sci 2009; 74(2):100–107.
Dranik G.N., Kurchenko A.I., Dranik A.G. Mucosal immune system, the physiological microflora and probiotics. Kiev: Poligraf plus; 2009.
Ermolenko E.I., Donets V.N., Dmitrieva Yu.V. et al. Effect of probiotic enterococci on the functional characteristics of the rat intestinal dysbiosis when induced by antibiotics. Vestnik of St. Petersburg University, Ser. 11: Medicine 2009; (1): 157–167.
Floch M.H. Recommendations for probiotic use in humans – A 2014 update. Pharmaceuticals 2014; 7 (10): 999–1007.
Grigoryev A.V. General principles of the human intestinal microbiota. Med Vsesvit 2002; (1–2): 168–173.
Guarner F., Khan A.G., Garisch J. et al. World Gastroenterology Organisation Global Guidelines: probiotics and prebiotics, october 2011. J Clin Gastroenterol 2012; 46 (6): 468–481. CrossRef PubMed
Guidelines for the evaluation of probiotics in food: Report of a joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. London, Ontario, Canada; 2002.
Intestinal dysbiosis. Guidelines for the diagnosis and treatment. St. Petersburg: InformMed; 2009.
Jankowski D.S. Microbial ecology of man: contemporary possibilities of its maintenance and recovery. Kiev: Expert LTD; 2005.
Kailasapathy K. Microencapsulation of Probiotic Bacteria: Technology and potential applications. Curr Issues Intest Microbiology 2002; 3 (2): 39–48. PubMed
Kharchenko N.V., Chernenko V.V., Yankovsky D.S., Dyment G.S. Role of the intestinal microflora in the development of chronic diseases of the gastrointestinal tract. Zhurnal Praktychnogo Likarya 2003; (4): 20–27.
Korolyuk A.M., Sboychakov V.B., editors. Medical microbiology. Part 1. St.-Petersburg: Meditsyna; 2002.
Krasowska A., Murzyn A., Dyjankiewicz A. et al. The antagonistic effect of Saccharomyces boulardii on Candida albicans filamentation, adhesion and biofilm formation. FEMS Yeast Research 2009; 9(8): 1312–1321. CrossRef PubMed
Lusta K.A., Fichte B.A. Methods for determining the viability of microorganisms. Pushchino; 1990. PubMed
Micklefield G. Saccharomyces boulardii in the treatment and prevention of antibiotic-associated diarrhea. MMW Fortschr Med 2014; 156 (13): 61. CrossRef PubMed
Morozov I.A. Problems of Helicobacter pylori morphological diagnosis in the stomach. Russian Journal of Gastroenterology 1999; (2): 46–48.
Polyak M.S., Sukharevich M.E., Sukharevich V.I. Culture media for medical microbiology. SPb; 2008: 53–56.
Simanenko V.I., editor. Clinical aspects of diagnosis and treatment of intestinal dysbiosis in general therapeutic practice. St. Petersburg; 2003.
Solovyeva I.V., Tochilina A.G., Belova I.V. et al. Construction of an immobilized form of the liquid probiotic. Vestnik of Nizhny Novgorod University named after N.I. Lobachevsky: Microbiology and Epidemiology 2012; (2, part 3): 85–92.
Tutchenko L.I., Ott V.D., Marushko T.L. et al. Peculiarities of microbiocenosis formation process in infants and newborns and the ways of its optimization. Zhurnal Praktychnogo Likarya 2003; (5): 24–30.
Vandenplas Y., Brunser O., Szajewska H. Saccharomyces boulardii in childhood. Eur J Pediatr 2009; 168 (3): 253–265. CrossRef PubMed
Volkov M.Yu. Effective forms of probiotics immobilized on natural adsorbents. Pischevye Ingredienty. Syrio i Dobavki 2007; (1): 48–51.
Vorob'ev A.A., Nesvizhskii Iu.V., Zudenkov A.E., Budanova E.V. Comparative study of parietal and lumen microflora in the large intestine in experiments on mice. Zhurnal Mikrobiologii, Epidemiologii i Immunologii 2001 Jan–Feb; (1): 62–67.
Vysekantsev I.P., Babinets O.M., Martsenyuk V.P., Shatilova L.E. Comparative study of adsorption of standard markers and Saccharomyces boulardii, Bifidobacterium bifidum probiotics on enterosorbents. Visnyk Problem Biologii i Meditsyny 2011; Issue 1: 58–62.
Williams N.T. Probiotics. Am J Health Sys Pharm 2010; 67(6): 449–458. CrossRef PubMed
Zapadnyuk I.P., Zapadnyuk V.I., Zacharias E.A., Zapadnyuk B.V. Laboratory animals. Breeding, keeping and use in experiment. Kiev: Vyshcha shkola, 1983: 383.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Igor P. Vysekantsev, Olga M. Babinets, Valentina F. Martsenyuk, Larisa Ye. Shatilova, Andrey V. Scheglov, Yulia V. Voyda
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
